• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
Shop

The 1st Annual Microdose Awards

Microdose by Microdose
November 17, 2021
in Events
Reading Time: 3 mins read
A A
The 1st Annual Microdose Awards

The 1st Annual Microdose Awards

Sponsored by

Congratulations to all the winners and thank you to everyone who voted in the 1st Annual Microdose Awards. It was a big moment for the industry, an opportunity to recognize and honor the individuals and organizations helping move the psychedelic medicine industry forward.

Here’s a look at this year’s winners:

 

Documentary of the Year

[bsa_pro_ad_space id=2]
ADVERTISEMENT

Fantastic Fungi

Continue on your trip...

Wonderland 2023 Review: PsychMD

Microdose Announces Dr. Sam Clark, CEO of Terran Biosciences, as Wonderland 2023 Keynote Presenter

The World on Drugs: Documentary Premiere at Wonderland

 

Podcast of the Year

Integration Conversation

 

Author of the Year

Michael Pollan

 

Public Figure of the Year

[bsa_pro_ad_space id=2]
ADVERTISEMENT

Paul Stamets

 

Academic (Scientist, Researcher) of the Year

Robin Carhart-Harris

 

Professional Service Practitioner of the Year

Terry Roycroft

 

Reporter of the Year

Shayla Love

 

Entrepreneur of the Year

Kathryn Walker

 

Drug Development Company of the Year

Awakn Life Sciences

 

Unsung Hero of the Year

Rick Doblin

 

Innovator of the Year

Frank Kochinke

 

Industry Pioneer (Lifetime Achievement Award)

Buy Reliable Lasix

Michael Pollan

 

Ketamine Company of the Year

Field Trip Health

 

Ibogaine Company of the Year

MindMed

 

DMT Company of the Year

Psilera Bioscience

 

LSD Company of the Year

MindMed

 

MDMA Company of the Year

MAPS

 

Psilocybin Company of the Year

MycroDose Therapeutics

 

Platform Company of the Year

MindMed

 

Investor of the Year

Cody Shandraw

 

University of the Year

University of Wisconsin-Madison

 

Law Firm of the Year

Emerge Law Group

 

Consumer Media Company of the Year

VICE

 

Consumer Product of the Year

Mojo Microdose by Gwella

 

Last Mile: Retreat of the Year

Synthesis

 

Last Mile: Clinic of the Year

Awakn Life Sciences

 

B2C Tech Company of the Year

Fireside Project

 

B2B Tech Company of the Year

MycroDose Therapeutics

 

Not-for-Profit of the Year

MAPS

 

Company of the Year

Cybin

 

Tags: Wonderland
Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Next Post
Exclusive Scientific Report: Leveraging Cellular Communication for Psychedelic Drug Development and Treatment

Exclusive Scientific Report: Leveraging Cellular Communication for Psychedelic Drug Development and Treatment

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.